Platelet activation dynamics evaluated using platelet-derived microparticles in Kawasaki disease

Circulation Journal

Volumn 78, Issue 1, 2014, Pages 188-193

  Yahata, Tomoyo ^a   Suzuki, Chinatsu ^a   Yoshioka, Ayako ^a   Hamaoka, Akiko ^a   Ikeda, Kazuyuki ^a  

^a KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

Author keywords

Antiplatelet therapy; Kawasaki disease; Platelet derived microparticle

Indexed keywords

ACETYLSALICYLIC ACID; IMMUNOGLOBULIN;

ARTICLE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; INFANT; MUCOCUTANEOUS LYMPH NODE SYNDROME; PLATELET MICROPARTICLE; PRESCHOOL CHILD; THROMBOCYTE ACTIVATION;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ASPIRIN; BLOOD PLATELETS; CELL-DERIVED MICROPARTICLES; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; IMMUNOLOGIC FACTORS; INFANT; MALE; MUCOCUTANEOUS LYMPH NODE SYNDROME; PLATELET ACTIVATION;

EID: 84891089239     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.CJ-12-1037     Document Type: Article

References (18)

1. Landing BH, Larson EJ. Pathological features of Kawasaki disease (mucocutaneous lymph node syndrome). Am J Cardiovasc Pathol 1987; 1: 218-229.
2. Naoe S, Takahashi K, Masuda H, Tanaka N. Kawasaki disease with particular emphasis on arterial lesions. Acta Pathol Jpn 1991; 41: 785-797.
3. Amano S, Hazama F, Hamashima Y. Pathology of Kawasaki disease: II. Distribution and incidence of the vascular lesions. Jpn Circ J 1979; 43: 741-748.
4. Giannotti G, Landmesser U. Endothelial dysfunction as an early sign of atherosclerosis. Herz 2007; 32: 568-572.
5. Newburger JW, Takahashi M, Beiser AS, Burns JC, Bastian J, Chung KJ, et al. A single intravenous infusion of gamma globulin as compared with four infusions in the treatment of acute Kawasaki syndrome. N Engl J Med 1991; 324: 1633-1639.
6. Taki M, Kobayashi M, Ohi C, Shimizu H, Goto K, Aso K, et al. Spontaneous platelet aggregation in Kawasaki disease using the particle counting method. Pediatr Int 2003; 45: 649-652.
7. Yamada K, Fukumoto T, Shinkai A, Shirahata A, Meguro T. The platelet functions in acute febrile mucocutaneous lymph node syndrome and a trial of prevention for thrombosis by antiplatelet agent. Nihon Ketsueki Gakkai Zasshi 1978; 41: 791-802.
8. Shirahata A, Nakamura T, Asakura A. Studies on blood coagulation and antithrombotic therapy in Kawasaki disease. Acta Paediatr Jpn 1983; 25: 180-191.
9. Nomura S. Function and clinical significance of platelet-derived microparticles. Int J Hematol 2001; 74: 397-404.
10. Italiano JE Jr, Mairuhu AT, Flaumenhaft R. Clinical relevance of microparticles from platelets and megakaryocytes. Curr Opin Hematol 2010; 17: 578-584.
11. Barry OP, Praticò D, Savani RC, FitzGerald GA. Modulation of monocyte-endothelial cell interactions by platelet microparticles. J Clin Invest 1998; 102: 136-144.
12. Barry OP, FitzGerald GA. Mechanisms of cellular activation by platelet microparticles. Thromb Haemost 1999; 82: 794-800.
13. Osumi K, Ozeki Y, Saito S, Nagamura Y, Ito H, Kimura Y, et al. Development and assessment of enzyme immunoassay for plateletderived microparticles. Thromb Haemost 2001; 85: 326-330.
14. Nomura S, Ozaki Y, Ikeda Y. Function and role of microparticles in various clinical settings. Thromb Res 2008; 123: 8-23.
15. Burnier L, Fontana P, Kwak BR, Angelillo-Scherrer A. Cell-derived microparticles in haemostasis and vascular medicine. Thromb Haemost 2009; 101: 439-451.
16. Sinauridze EI, Kireev DA, Popenko NY, Pichugin AV, Panteleev MA, Krymskaya OV, et al. Platelet microparticle membranes have 50-to 100-fold higher specific procoagulant activity than activated platelets. Thromb Haemost 2007; 97: 425-434.
17. Nomura S, Uehata S, Saito S, Osumi K, Ozeki Y, Kimura Y. Enzyme immunoassay detection of platelet-derived microparticles and RANTES in acute coronary syndrome. Thromb Haemost 2003; 89: 506-512.
18. Nomura S, Shouzu A, Taomoto K, Togane Y, Goto S, Ozaki Y, et al. Assessment of an ELISA kit for platelet-derived microparticles by joint research at many institutes in Japan. J Atheroscler Thromb 2009; 16: 878-887.